crestor 20 mg film-coated tablets
astrazeneca ab se-151 85, södertälje, sweden - rosuvastatin - film-coated tablet - rosuvastatin 20 mg - lipid modifying agents
crestor 20 mg film-coated tablets
imbat limited - rosuvastatin - film-coated tablet - 20 milligram(s) - hmg coa reductase inhibitors; rosuvastatin
crestor 20 mg film-coated tablets
astrazeneca uk limited - rosuvastatin calcium - film-coated tablet - 20 milligram(s) - hmg coa reductase inhibitors; rosuvastatin
crestor 20 mg film-coated tablets
imed healthcare ltd. - rosuvastatin - film-coated tablet - 20 milligram(s) - hmg coa reductase inhibitors; rosuvastatin
crestor 20 mg film-coated tablets
pco manufacturing ltd. - rosuvastatin - film-coated tablet - 20 milligram(s) - rosuvastatin
crestor 20 mg film-coated tablets
astrazeneca ab - rosuvastatin - film-coated tablet - 20 milligram(s) - hmg coa reductase inhibitors; rosuvastatin
crestor 20 mg film-coated tablets
grunenthal pharma ltd - rosuvastatin - film-coated tablet - hmg coa reductase inhibitors; rosuvastatin
crestor
a. menarini new zealand pty ltd - rosuvastatin calcium 20.8mg equivalent to rosuvastatin 20mg; - film coated tablet - 20 mg - active: rosuvastatin calcium 20.8mg equivalent to rosuvastatin 20mg excipient: calcium phosphate crospovidone hypromellose iron oxide red lactose monohydrate magnesium stearate microcrystalline cellulose purified water titanium dioxide triacetin - crestor should be used as an adjunct to diet when the response to diet and exercise is inadequate. prevention of major cardiovascular events in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease, (see clinical efficacy) crestor is indicated to: reduce the risk of nonfatal myocardial infarction reduce the risk of nonfatal stroke reduce the risk of coronary artery revascularisation
crestor 20 mg tablets film-coated tablet
astrazeneca parklands alderley park macclesfield cheshire - rosuvastatin calcium - film-coated tablet - each tablet contains 20 mg rosuvastatin (as - plain lipid modifying agents: hmg coa reductase
crestor 20mg film-coated tablets
pco manufacturing - rosuvastatin - coated tablets - 20mg milligram